Year |
Citation |
Score |
2024 |
Hu X, Zhao M, Bai M, Xue Z, Wang F, Zhu Z, Yu J, Yue J. PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutation. Cancer Letters. 216676. PMID 38278469 DOI: 10.1016/j.canlet.2024.216676 |
0.316 |
|
2023 |
Liu C, Li X, Huang Q, Zhang M, Lei T, Wang F, Zou W, Huang R, Hu X, Wang C, Zhang X, Sun B, Xing L, Yue J, Yu J. Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. Signal Transduction and Targeted Therapy. 8: 44. PMID 36710358 DOI: 10.1038/s41392-022-01264-9 |
0.319 |
|
2022 |
Shen X, Zhang B, Hu X, Li J, Wu M, Yan C, Yang Y, Li Y. and inhibited oral squamous cell carcinomas by regulating genome stability. Bioengineered. 13: 14094-14106. PMID 35734856 DOI: 10.1080/21655979.2022.2078556 |
0.326 |
|
2022 |
Hu X, Li L, Eid JE, Liu C, Yu J, Yue J, Trent JC. IDH1 Mutation Induces HIF-1 and Confers Angiogenic Properties in Chondrosarcoma JJ012 Cells. Disease Markers. 2022: 7729968. PMID 35198082 DOI: 10.1155/2022/7729968 |
0.319 |
|
2020 |
Wang L, Gao Y, Zhang G, Li D, Wang Z, Zhang J, Hermida LC, He L, Wang Z, Si J, Geng S, Ai R, Ning F, Cheng C, Deng H, ... ... Hu X, et al. Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade. Science Translational Medicine. 12. PMID 32908002 DOI: 10.1126/Scitranslmed.Aax2282 |
0.306 |
|
2019 |
Xiao Z, Chang L, Kim J, Zhang P, Hang Q, Yap S, Guo Y, Zhou Z, Zeng L, Hu X, Siverly A, Sun Y, Ma L. USP37 is a SNAI1 deubiquitinase. American Journal of Cancer Research. 9: 2749-2759. PMID 31911859 |
0.382 |
|
2019 |
Li L, Hu X, Trent JC. Depletion of mutant IDH1 impairs chondrosarcoma growth by downregulating integrins. Journal of Clinical Oncology. 37: 11031-11031. DOI: 10.1200/JCO.2019.37.15_SUPPL.11031 |
0.315 |
|
2018 |
Chu Y, Wang Y, Peng W, Xu L, Liu M, Li J, Hu X, Li Y, Zuo J, Ye Y. STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis. Biochemical and Biophysical Research Communications. PMID 29684351 DOI: 10.1016/j.bbrc.2018.04.121 |
0.328 |
|
2017 |
Zhou Z, Zhang P, Hu X, Kim J, Yao F, Xiao Z, Zeng L, Chang L, Sun Y, Ma L. USP51 promotes deubiquitination and stabilization of ZEB1. American Journal of Cancer Research. 7: 2020-2031. PMID 29119051 |
0.358 |
|
2017 |
Zhang Y, Xu W, Guo H, Zhang Y, He Y, Lee SH, Song X, Li X, Guo Y, Zhao Y, Ding C, Ning F, Ma Y, Lei QY, Hu X, et al. NOTCH1 Signaling Regulates Self-renewal and Platinum Chemoresistance of Cancer Stem-like Cells in Human Non-small Cell Lung Cancer. Cancer Research. PMID 28416482 DOI: 10.1158/0008-5472.CAN-16-1633 |
0.313 |
|
2015 |
Zeng M, Yang Z, Hu X, Liu Y, Yang X, Ran H, Li Y, Li X, Yu Q. Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer. International Journal of Clinical and Experimental Pathology. 8: 11296-304. PMID 26617853 |
0.358 |
|
2014 |
Hu X, Zhou Y, Dong K, Sun Z, Zhao D, Wang W, Yu G, Liu W, Xu G, Han Z, Feng X. Programming of the development of tumor-promoting neutrophils by mesenchymal stromal cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 33: 1802-14. PMID 24923759 DOI: 10.1159/000362959 |
0.311 |
|
2013 |
Hu X, Dutta P, Tsurumi A, Li J, Wang J, Land H, Li WX. Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 110: 10213-8. PMID 23733954 DOI: 10.1073/Pnas.1221243110 |
0.364 |
|
2013 |
Qian X, Gu L, Ning H, Zhang Y, Hsueh EC, Fu M, Hu X, Wei L, Hoft DF, Liu J. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. Journal of Immunology (Baltimore, Md. : 1950). 190: 5894-902. PMID 23645882 DOI: 10.4049/Jimmunol.1203141 |
0.322 |
|
Show low-probability matches. |